Grant: Engage Grants Program
University of British Columbia
$24,100.00
Optical fibre detectors for radiation beam characterization and dosimetry
EF 2016-17
Résumé
Founded in 1995, D-Pace is located in Nelson, BC, Canada, and supplies high-quality precision equipment andservices to the particle accelerator industry. In 2015 D-Pace licensed a new technology from the University ofBern, called UniBEaM. UniBEaM is a beam profiling system, which end users can use to provide feedbackwhen aligning, steering, focussing, shaping and validating particle and x-ray beams. The system can be used toincrease safety and improve production yields for commercial users. D-Pace recently completed acomprehensive marketing survey which identified new market segments where this technology can be used,including medical diagnostics and therapy. To enter these markets D-Pace needs to provide quantitative data toconvince these industries of the effectiveness of the system. This is the goal of this project.UniBEaM uses two optical sensor fibers, made of cerium-doped silica, that scintillate in a particle or X-raybeam. Sensitive detectors are used to measure this light and display the profile of the beam. UniBEaM hasbeen tested on an 18 MeV cyclotron used to produce radiopharmaceuticals, but D-Pace needs to thoroughly testthe system with beams used for medical therapies, including X-rays, electrons, protons and neutrons. D-Pacerequires data, including signal-to-noise ratios at different beam energies and dose rates, signal linearity, andchanges in fiber sensitivity with beam exposure time.Through the BC Cancer Agency in Kelowna, Dr. Jirasek, director of the UBC-Okanagan Graduate MedicalPhysics program, has access to clinical medical linear accelerators operating in the MV energy range. Theseaccelerators will be used to characterize the performance of UniBEaM with electron and X-Rays, using NISTtraceable ionization chambers as a standard for comparison. UniBEaM will also be tested in Vancouver, onTRIUMF's Proton Therapy Facility with proton (to 74MeV) and neutron beams (to 120MeV).
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
507425-2016
Name nom
Jirasek, Andrew
Department département
Okanagan - Computer Science, Mathematics, Physics and Statistics
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
24100
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3115
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Medical Physics
Research subject fr
Physique médicale
Partie
1
Nb partie
1
Application title
Optical fibre detectors for radiation beam characterization and dosimetry
Keyword
NSERC
Application summary
Founded in 1995, D-Pace is located in Nelson, BC, Canada, and supplies high-quality precision equipment andservices to the particle accelerator industry. In 2015 D-Pace licensed a new technology from the University ofBern, called UniBEaM. UniBEaM is a beam profiling system, which end users can use to provide feedbackwhen aligning, steering, focussing, shaping and validating particle and x-ray beams. The system can be used toincrease safety and improve production yields for commercial users. D-Pace recently completed acomprehensive marketing survey which identified new market segments where this technology can be used,including medical diagnostics and therapy. To enter these markets D-Pace needs to provide quantitative data toconvince these industries of the effectiveness of the system. This is the goal of this project.UniBEaM uses two optical sensor fibers, made of cerium-doped silica, that scintillate in a particle or X-raybeam. Sensitive detectors are used to measure this light and display the profile of the beam. UniBEaM hasbeen tested on an 18 MeV cyclotron used to produce radiopharmaceuticals, but D-Pace needs to thoroughly testthe system with beams used for medical therapies, including X-rays, electrons, protons and neutrons. D-Pacerequires data, including signal-to-noise ratios at different beam energies and dose rates, signal linearity, andchanges in fiber sensitivity with beam exposure time.Through the BC Cancer Agency in Kelowna, Dr. Jirasek, director of the UBC-Okanagan Graduate MedicalPhysics program, has access to clinical medical linear accelerators operating in the MV energy range. Theseaccelerators will be used to characterize the performance of UniBEaM with electron and X-Rays, using NISTtraceable ionization chambers as a standard for comparison. UniBEaM will also be tested in Vancouver, onTRIUMF's Proton Therapy Facility with proton (to 74MeV) and neutron beams (to 120MeV).